Harmony Biosciences Holdings (HRMY) Share-based Compensation (2019 - 2026)
Harmony Biosciences Holdings' Share-based Compensation came in at $9.34 million for Q2 2026, down 18.5% from $11.46 million a year earlier and down 12.1% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Harmony Biosciences Holdings reported Share-based Compensation of $40.9 million, down 9.3% year-over-year; for FY2025, it came in at $44.9 million, up 5.4% from FY2024.
- Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 57.1% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $42.6 million in FY2024 (+34.4%), $31.71 million in FY2023 (+21.1%), $26.17 million in FY2022 (+67.1%) and $15.66 million in FY2021 (+233.7%).
- The Q2 2026 figure represents the lowest quarterly Share-based Compensation since Q4 2023.
- Year-over-year, Share-based Compensation has declined for four consecutive quarters, with growth averaging 5.0% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 296.4%), and the weakest in Q2 2026 (a decline of 18.5%).
- Business Quant data shows HRMY's Share-based Compensation at $10.62 million (Q1 2026), $9.97 million (Q4 2025) and $10.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 9.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.34 Mn |
| Mar 31, 2026 | 10.62 Mn |
| Dec 31, 2025 | 9.97 Mn |
| Sep 30, 2025 | 10.97 Mn |
| Jun 30, 2025 | 11.46 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 10.07 Mn |
| Sep 30, 2024 | 11.05 Mn |
| Jun 30, 2024 | 11.09 Mn |
| Mar 31, 2024 | 10.39 Mn |
| Dec 31, 2023 | 8.86 Mn |
| Sep 30, 2023 | 7.99 Mn |
| Jun 30, 2023 | 7.65 Mn |
| Mar 31, 2023 | 7.20 Mn |
| Dec 31, 2022 | 7.26 Mn |
| Sep 30, 2022 | 7.01 Mn |
| Jun 30, 2022 | 7.28 Mn |
| Mar 31, 2022 | 4.63 Mn |
| Dec 31, 2021 | 4.20 Mn |
| Sep 30, 2021 | 4.25 Mn |
API Access
Harmony Biosciences Holdings Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();